Healthnostics, Inc. (PINK:HNSS) has been steadily moving up since the beginning of 2012, although it’s very hard to find a reason for such a performance.
Last Friday, HNSS closed up 27.27% at $0.0014 with over 5 million shares traded, and at the time of this writing HNSS is up another 42.86% at $0.002 per share.
While there seems to be some excitement about the stock, the company itself is one of the sub-pennies which a lot of traders avoid.
HNSS bears the stop sign on OTCMarkets, and has not provided any financial information since Sept. 30, 2011 when it published its interim financial report for the period ended Jun. 30, 2011.[BANNER]
The latest press release dates to Oct. 11 when the company said it had decided to move the launch of its supposed “game-changer” MicroFill-2160 to the first quarter of 2012.
There is in fact very little solid information available for HNSS to justify any valuation at this point. The current market performance of HNSS is not inspired by developments in the company or its operations, but rather it seems to be based on speculation and some momentum.
